Application of chiral-specificity of amino acids on the novel development of antipsychotic drugs for schizophrenia
Project/Area Number |
26461713
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Psychiatric science
|
Research Institution | Tokyo Metropolitan Tama Medical Center (Department of Clinical Research) (2016-2017) Tokyo Medical and Dental University (2014-2015) |
Principal Investigator |
YAMAMOTO Naoki 東京都立多摩総合医療センター(臨床研究・教育研修センター(臨床研究部)), 精神神経科, 部長 (70312296)
|
Project Period (FY) |
2014-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | D-セリン / NMDA受容体 / 統合失調症 / D-アミノ酸 / グリシン / グルタミン酸 / NMDA / PCP / D-アミノ酸 |
Outline of Final Research Achievements |
In this study I have focused on chiral-specificity of amino acids to understand molecular basis in developing novel antipsychotic drugs for schizophrenia. D-Serine, an NMDA receptor coagonist, plays a crucial role in neurocognitive functions. From a pathophysiological aspect, dysfunction of D-serine/NMDA receptor signaling system may be involved in schizophrenia-related symptoms. To obtain further insights into the molecular basis of schizophrenia and other related mental disorders, I have investigated the genetic association of candidate genes and schizophrenia as case-control study. I obtained profiles of the relationship of these genes, including the splicing system of them, and schizophrenia.
|
Report
(5 results)
Research Products
(16 results)
-
[Journal Article] Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta- mannosyltransferase genes with schizophrenia in a Japanese population.2018
Author(s)
Momoko Kobayashi, Daisuke Jitoku, Yoshimi Iwayama, Naoki Yamamoto, Tomoko Toyota, Katsuaki Suzuki, Mitsuru Kikuchi, Tasuku Hashimoto, Nobuhisa Kanahara, Akeo Kurumaji, Takeo Yoshikawa, Toru Nishikawa
-
Journal Title
PLoS ONE
Volume: 13
Issue: 1
Pages: e0190991-e0190991
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Association of schizophrenia onset age and white matter integrity with treatment effect of D-cycloserine: a randomized placebo- controlled double-blind crossover study2017
Author(s)
Kazuo Takiguchi, Akihito Uezato, Michio Itasaka, Hidenori Atsuta, Kenji Narushima, Naoki Yamamoto, Akeo Kurumaji, Makoto Tomita, Kazunari Oshima, Kosaku Shoda, Mai Tamaru, Masahito Nakataki, Mitsutoshi Okazaki, Sayuri Ishiwata, Yasuyoshi Ishiwata, Masato Yasuhara, Kunimasa Arima,Tetsuro Ohmori, Toru Nishikawa
-
Journal Title
BMC Psychiatry,
Volume: 17
Issue: 1
Pages: 249-263
DOI
NAID
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Genetic and molecular risk factors within the newly identified primate-specific exon of the SAP97/DLG1 gene in the 3q29 schizophrenia-associated locus.2017
Author(s)
Akihito Uezato, Naoki Yamamoto, Daisuke Jitoku, Emiko Haramo, Eri Hiraaki, Yoshimi Iwayama, Tomoko Toyota, Masakazu Umino, Asami Umino, Yasuhide Iwata, Katsuaki Suzuki, Mitsuru Kikuchi, Tasuku Hashimoto, Nobuhisa Kanahara, Akeo Kurumaji, Takeo Yoshikawa, Toru Nishikawa.
-
Journal Title
American Journal of Medical Genetics(Part B): Neuropsychiatric_Genetics,
Volume: 174
Issue: 8
Pages: 798-804
DOI
Related Report
Peer Reviewed / Int'l Joint Research
-
-
-
[Journal Article] Association study of H2AFZ with schizophrenia in a Japanese case-control sample.2015
Author(s)
Jitoku D, Yamamoto N, Iwayama Y, Toyota T, Miyagi M, Enokida T, Tasaka Y, Umino M, Umino A, Uezato A, Iwata Y, Suzuki K, Kikuchi M, Hashimoto T, Kanahara N, Kurumaji A, Yoshikawa T, Nishikawa T.
-
Journal Title
J Neural Transm
Volume: 122
Pages: 915-923
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-